September 17, 2020
Track this case
3:20-cv-06522
California Northern
Anti-Trust
Class Action
Kandis A. Westmore
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Gilead Sciences Inc. was accused in a new proposed antitrust class action of scheming to keep generic alternatives of its HIV treatment Truvada off the market by paying another drugmaker not to compete.
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Phone Number (###-###-####)
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Job Title
Law360 Healthcare Authority may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.